Cargando…
Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes
INTRODUCTION: Studies have reported that antidiabetic medications (ADMs) were associated with lower risk of dementia, but current findings are inconsistent. This study compared the risk of dementia onset in patients with type 2 diabetes (T2D) treated with sulfonylurea (SU) or thiazolidinedione (TZD)...
Autores principales: | Tang, Xin, Brinton, Roberta Diaz, Chen, Zhao, Farland, Leslie V, Klimentidis, Yann, Migrino, Raymond, Reaven, Peter, Rodgers, Kathleen, Zhou, Jin J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472121/ https://www.ncbi.nlm.nih.gov/pubmed/36220195 http://dx.doi.org/10.1136/bmjdrc-2022-002894 |
Ejemplares similares
-
Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial
por: Davis, Stephen N., et al.
Publicado: (2019) -
Association between hemoglobin A1c variability and hypoglycemia-related hospitalizations in veterans with diabetes mellitus
por: Zhao, Molly J Y, et al.
Publicado: (2021) -
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
por: Saremi, Aramesh, et al.
Publicado: (2017) -
Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
por: Koska, Juraj, et al.
Publicado: (2018) -
Impact of pharmacological treatment of diabetes mellitus on dementia risk: systematic review and meta-analysis
por: McMillan, Jacqueline M, et al.
Publicado: (2018)